A Team Model of Hypertension Care in African Americans
非裔美国人高血压护理的团队模式
基本信息
- 批准号:7497793
- 负责人:
- 金额:$ 22.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-30 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAdverse effectsAdverse reactionsAffectAfrican AmericanAmericanAreaBehaviorBeliefBlood PressureBlood Pressure MonitorsCaringCertificationCharacteristicsChicagoChronic Kidney FailureClinicClinical PharmacistsCollaborationsCommunicationCommunitiesCommunity PharmacyCounselingDiabetes MellitusDrug CostsEducational process of instructingEffectiveness of InterventionsEnd PointEnrollmentEnvironmentGuidelinesHealth SciencesHealth systemHealthcare SystemsHuman ResourcesHypertensionInstitutionalizationInterventionLife StyleMeasurementMeasuresMedicalMedical centerModelingMonitorOrganizational ChangeOutcomePatient EducationPatient NoncompliancePatientsPharmaceutical PreparationsPharmacistsPharmacy EducationPharmacy facilityPhysiciansProcessProviderPsychological reinforcementRandomizedRandomized Controlled TrialsRateRecommendationReportingResearch PersonnelRoleServicesSiteTestingTimeTrainingTreatment ProtocolsTreatment outcomeVeteransWorkbaseblood pressure regulationcompliance behaviorcostcost effectivenessdesignimprovedmedication compliancenondrug therapyprescription documentprescription procedureprogramsskillstherapy designtool
项目摘要
Despite efficacious drug and non-drug treatments, fewer than 50% of treated African American patients
achieve adequate hypertension control (<140/90 mm Hg or <130/80 mm HG for patients with diabetes or
chronic kidney disease). Studies suggest many reasons for lack of progress in this area, including patient
nonadherence, suboptimal prescribing, and ineffective communication among patients, physicians, and
3harmacists.
This study will evaluate the cost-effectiveness of an organizational-level intervention in a randomized
sontrolled trial involving 900 treated hypertensive African American patients in the Milwaukee and Chicago
areas. The study will involve 36 community pharmacies (18 intervention, 18 control) owned by a pharmacy
corporation that operates over 2,000 pharmacies nationwide. The intervention will include: a) redefinition of
pharmacist and pharmacy technician roles, b) implementation of a pharmacy-based "refill clinic" and tools for
enhanced monitoring and collaboration with patients and physicians, and c) special training/certification of
pharmacy personnel in blood pressure measurement, collaborative skills, and cultural competency.
Hypertension control rates (primary endpoint) will be measured at- baseline, six months, and 12 months.
Researchers will analyze the cost-effectiveness of the intervention, whether the recommended practices
were implemented and continued over time, and ways in which the intervention affected the process of care
(including pharmacist behavior, patient-reported barriers, prescribed regimens, and patient adherence). If
the intervention is successful, researchers will implemement and evaluate a dissemination plan for improving
pharmacy-based care of hypertensive patients nationwide. The study is unique because it tests relatively
simple and low cost interventions in the community pharmacy, an environment which is one of the most
readily accessible components of the health care system.
尽管药物和非药物治疗有效,但接受治疗的非洲裔美国患者中只有不到50%
达到足够的高血压控制(<140/90 mm Hg或<130/80 mm Hg,对于糖尿病患者或
慢性肾病)。研究表明,这一领域缺乏进展的原因有很多,包括患者
不依从、次优处方以及患者、医生和
3.有害。
本研究将在一个随机化的研究中评估组织层面干预的成本效益。
在密尔沃基和芝加哥进行的一项涉及900名接受高血压治疗的非裔美国人患者的sontrolled试验
地区该研究将涉及36个社区药店(18个干预,18个对照),
该公司在全国经营着2,000多家药店。干预措施将包括:
B)实施基于药房的“补充诊所”和工具,
加强监测以及与病人和医生的合作,以及c)对
药学人员在血压测量,协作技能和文化能力。
将在基线、6个月和12个月时测量高血压控制率(主要终点)。
研究人员将分析干预措施的成本效益,
实施并持续一段时间,以及干预影响护理过程的方式
(包括药剂师行为、患者报告的障碍、处方方案和患者依从性)。如果
干预是成功的,研究人员将实施和评估传播计划,以改善
在全国范围内为高血压患者提供以药房为基础的护理。这项研究是独一无二的,因为它测试了相对
社区药房的简单和低成本干预措施,这是一个最重要的环境之一,
卫生保健系统中容易获得的组成部分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BONNIE L SVARSTAD其他文献
BONNIE L SVARSTAD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BONNIE L SVARSTAD', 18)}}的其他基金
A Team Model of Hypertension Care in African Americans
非裔美国人高血压护理的团队模式
- 批准号:
6951986 - 财政年份:2004
- 资助金额:
$ 22.46万 - 项目类别:
A Team Model of Hypertension Care in African Americans
非裔美国人高血压护理的团队模式
- 批准号:
6846661 - 财政年份:2004
- 资助金额:
$ 22.46万 - 项目类别:
A Team Model of Hypertension Care in African Americans
非裔美国人高血压护理的团队模式
- 批准号:
7460614 - 财政年份:2004
- 资助金额:
$ 22.46万 - 项目类别:
A Team Model of Hypertension Care in African Americans
非裔美国人高血压护理的团队模式
- 批准号:
7271974 - 财政年份:2004
- 资助金额:
$ 22.46万 - 项目类别:
A Team Model of Hypertension Care in African Americans
非裔美国人高血压护理的团队模式
- 批准号:
7113106 - 财政年份:2004
- 资助金额:
$ 22.46万 - 项目类别:
PREDICTING THE USE OF SLEEP MEDICATIONS IN NURSING HOMES
预测疗养院中睡眠药物的使用情况
- 批准号:
3115636 - 财政年份:1985
- 资助金额:
$ 22.46万 - 项目类别:
PREDICTING THE USE OF SLEEP MEDICATIONS IN NURSING HOMES
预测疗养院中睡眠药物的使用情况
- 批准号:
3115639 - 财政年份:1985
- 资助金额:
$ 22.46万 - 项目类别:
PREDICTING THE USE OF SLEEP MEDICATIONS IN NURSING HOMES
预测疗养院中睡眠药物的使用情况
- 批准号:
3115638 - 财政年份:1985
- 资助金额:
$ 22.46万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 22.46万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 22.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 22.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 22.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 22.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 22.46万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 22.46万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 22.46万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 22.46万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 22.46万 - 项目类别:
Studentship














{{item.name}}会员




